Mednet Logo
SpecialtiesGeriatric Medicine
Geriatric Medicine

Geriatric Medicine

Physician insights on aging-related care, polypharmacy management, cognitive decline, and geriatric syndromes.

Recent Discussions

When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?

3
2 Answers

Mednet Member
Mednet Member
Rheumatology · Icahn School of Medicine at Mount Sinai

Some background: In patients discontinuing denosumab without subsequent antiresorptive therapy, BMD rapidly reverts back to baseline with an elevation in vertebral fracture risk (with an enhanced risk of multiple vertebral fractures). Thus, sequential treatment regimens following denosumab have been...

What go-to resources do you recommend if patients would like to discuss voluntary stopping eating and drinking (VSED) as part of advance care planning, for example, for consideration should they develop advanced dementia in the future?

1 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Brown University

This will be very dependent on location, but traditionally, if this is becoming a topic, they should be referred to outpatient palliative care, and when the time is close, hospice, as most of these patients get significant symptoms. Lastly, depending on local laws, this might not be allowed for deme...

How do you approach the choice of basal-bolus insulin vs correctional insulin alone to manage hyperglycemia in a hospitalized older adult with type 2 diabetes and significant frailty?

3 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Brown University

Frail older adults with type 2 diabetes, compared to their less-frail counterparts, may have less predictable oral intake, and you may have more difficulty obtaining an accurate medication reconciliation. You may need to review facility records or speak to multiple collateral historians to find out ...

What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?

8
3 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Case Western Reserve University/University Hospitals Cleveland Medical Center

Hope for the miracle yourself! Broaden: “Are there any other things you are hoping for?” Hope for the best, prepare for the worst: “I see how much you want a miracle. I wonder if we can talk about what we should do if this doesn’t happen.” Consider involving a religious leader if relevant.

How do you counsel older adults regarding the use of melatonin (dose and timing) for sleep-related problems?

3 Answers

Mednet Member
Mednet Member
Geriatric Medicine · David Geffen School of Medicine (UCLA)

Melatonin is likely helpful, but patients need to feel comfortable that the melatonin they bought actually contains melatonin, so it's best to suggest that they buy products that have been separately tested. I also feel the need to keep circadian rhythms in mind, so I try to have patients take it as...

What is your antipsychotic of choice and general titration regimen in the outpatient setting for a patient with dementia and behavioral disturbances (assuming reversible causes such as urinary retention, constipation, etc. have been addressed)?

6
3 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Twin Cities Physicians

While not set in stone and knowing that there is a black box warning, make sure you get informed consent. I start with low doses of quetiapine (12.5 to 25 mg), as it has the shortest half-life, and will use it twice or 3 times a day. This allows for quicker recovery if they are too sedated. Dependin...

When is it useful to test for multiple amyloid-related biomarkers for patients undergoing work-up for cognitive impairment?

6
1 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Wake Forest University School of Medicine

If a patient has a presentation consistent with MCI or early dementia due to AD (slow progressive decline, STM loss, no hallucinations, no neuro deficits), I will get an MRI and amyloid blood-based biomarkers. If the goal is just a diagnosis, I stop there. If they are interested in “mab” therapy, I ...

How do you approach the decision to initiate or continue bisphosphonate therapy in an older patient with significant esophageal disease or swallowing dysfunction?

1 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Massachusetts General Hospital

Unless there are indications to turn first to non-bisphosphonate therapies, I would first consider whether the patient would be a candidate for IV bisphosphonate therapy. Many patients, even those without esophageal disease or dysphagia, find the convenience of an annual outpatient infusion appealin...

What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?

2
1 Answers

Mednet Member
Mednet Member
Nephrology · U Chicago

The biggest difference between osteoporosis and CKD-MBD has to do with the underlying bone mineral laboratories. Generally, with osteoporosis, bone chemistries are relatively normal; there may be a decrease in Vit D. However, with CKD-MBD, there is usually an increase in PTH, potentially abnormaliti...

Have you used lithium for agitation in dementia?

1
1 Answers

Mednet Member
Mednet Member
Psychiatry · UCLA

Non-pharmacologic approaches are first indicated. If they fail, then a psychotropic treatment algorithm is indicated, which generally starts with a serotonin reuptake inhibitor. Lithium would not be considered standard or first-line treatment for agitation in Alzheimer's disease, and in most other m...